ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1041

A Theory of Change for Patient-Initiated Follow-Up Care in Rheumatoid Arthritis

Manuel Ester1, Krista White2, Kiran Dhiman2, Saania Zafar2, Alexandra Charlton3, Glen Hazlewood4, Gabrielle L. Zimmermann5, Alison Hoens6, Sarah L. Manske7, Diane Lacaille8, Mark G. Perry9, Megan R.W. Barber10, Aurore Fifi-Mah4, Niki Panich11, Monika Szpunar12, Karen Then13, Kelly Osinski14, Shakeel Subdar15, Hafsah Al-Azem16, Michelle Jung16 and Claire Barber4, 1McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary; O’Brien Institute for Public Health, Cumming School of Medicine, University of Calgary; Arthritis Research Canada, Calgary, AB, Canada, 2McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3Division of Rheumatology, Cumming School of Medicine, Calgaru, AB, Canada, 4University of Calgary, Calgary, AB, Canada, 5Alberta SPOR SUPPORT Unit – Learning Health System Team, Department of Medicine, University of Alberta; 6. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Edmonton, AB, Canada, 6Arthritis Research Canada; Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, 7McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary; Department of Radiology, University of Calgary, Calgary, AB, Canada, 8Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 9Department of Rheumatology, University Hospitals Plymouth; Peninsula Medical School, Plymouth, England, United Kingdom, 10Arthritis Research Canada; Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada, 11Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 12Arthritis Research Canada, Toronto, ON, Canada, 13Faculty of Nursing, University of Calgary, Calgary, AB, Canada, 14Alberta Health Services, Edmonton, AB, Canada, 15Temerty School of Medicine, University of Toronto, Toronto, ON, Canada, 16Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada

Meeting: ACR Convergence 2024

Keywords: Access to care, Health Services Research, quality of care, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Health Services Research – ACR/ARP Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Timely, high-quality care is critical to effective rheumatoid arthritis (RA) management. Due to the resource-intensive nature of routine lifelong follow-ups and rheumatologist shortages, RA care needs in the province of Alberta (population: 4.4 million) are not being met. Over 3000 individuals are waiting to see a rheumatologist, while existing patients with urgent health concerns (e.g. RA flares) cannot access follow-up care in a timely manner. Additionally, 20-50% of routine follow-ups at 3-12-month intervals may be unnecessary (i.e. no treatment changes or new concerns). Patient-initiated models, where follow-up intervals are extended beyond 12 months according to patient needs, can reduce inefficiencies and improve care access. To address RA care challenges in Alberta, we co-developed a theory of change (TOC) for patient-initiated follow-up care.

Methods: A TOC details an intervention and its intended impact on outcomes of interest. Its creation requires a structured process wherein partners collaboratively define health services interventions for implementation testing. We worked with a diverse team of 35 healthcare leaders, implementation experts, and patient partners to co-develop a TOC for patient-initiated RA follow-up care. A 3-phase approach was used (Figure 1). During the scoping phase, we held informal discussions with healthcare leaders and reviewed evidence on patient-initiated follow-up models to assess their implementation potential. During the development phase, we drafted a TOC map using scoping phase findings and clinical and patient expertise (Figure 2). During the refinement phase, we iteratively adapted the TOC with healthcare and patient partners. Anonymous feedback was collected via polls. Meetings were recorded, transcribed, and analyzed using inductive thematic content analysis alongside poll results and informal feedback to guide TOC refinement.

Results: The scoping phase detailed challenges in RA care (i.e. lengthy waitlists, unnecessary appointments) and the potential of a patient-initiated follow-up model to address them. TOC discussions highlighted two themes about the model’s intended impact: (1) efficient and effective care for patients when needed, and (2) a more sustainable RA care model. After drafting the TOC map, partner feedback in the refinement phase covered 4 topics: (1) preference for an interdisciplinary flare clinic over a shared care model with primary care, (2) patient selection, (3) patient education, and (4) patient monitoring. Tools and strategies were co-developed with our partners to better support patients (e.g. a decision tool to prompt patient-provider discussion around suitability) and the health system (e.g. monthly team meetings to monitor provider burden). The final TOC for patient-initiated follow-up in RA details the care pathway, key resources and considerations, and evaluation outcomes.

Conclusion: A patient-centered, contextually tailored model for patient-initiated RA follow-up care was co-developed with patient and healthcare partner input. Next, an implementation pilot will test its safety, feasibility, and effectiveness for addressing RA care challenges.

Supporting image 1

The 3-phase TOC process and key partners involved during each phase.

Supporting image 2

The TOC map for Appointments by Choice for Rheumatoid Arthritis after phase 2 of the TOC process.


Disclosures: M. Ester: None; K. White: None; K. Dhiman: None; S. Zafar: None; A. Charlton: None; G. Hazlewood: None; G. Zimmermann: None; A. Hoens: None; S. Manske: None; D. Lacaille: None; M. Perry: None; M. Barber: AbbVie/Abbott, 1, AstraZeneca, 1, GlaxoSmithKlein(GSK), 1, 2, Janssen, 1, sanofi genzyme, 1; A. Fifi-Mah: AbbVie/Abbott, 1, Fresenius kabi, 1, novartis, 1, otsuka, 1, Pfizer, 5, Sobi, 1; N. Panich: None; M. Szpunar: None; K. Then: None; K. Osinski: None; S. Subdar: None; H. Al-Azem: None; M. Jung: None; C. Barber: None.

To cite this abstract in AMA style:

Ester M, White K, Dhiman K, Zafar S, Charlton A, Hazlewood G, Zimmermann G, Hoens A, Manske S, Lacaille D, Perry M, Barber M, Fifi-Mah A, Panich N, Szpunar M, Then K, Osinski K, Subdar S, Al-Azem H, Jung M, Barber C. A Theory of Change for Patient-Initiated Follow-Up Care in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/a-theory-of-change-for-patient-initiated-follow-up-care-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-theory-of-change-for-patient-initiated-follow-up-care-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology